Multi-Industry Comments on the Voluntary Disclosure of Sesame as an Allergen
ASTA signed onto industry coalition comments to the Food and Drug Administration (FDA) in February 2021 regarding the FDA's draft guidance titled Voluntary Disclosure of Sesame as an Allergen.
02/25/2021 at 5:15 am
1
Related Resources
Multi-Industry Letter to FDA on Possible Use of 3rd Party Audit Data
ASTA signed onto a letter from multiple industries to FDA's Associate Commissioner Michael Rogers in September 2024 requesting a meeting to discuss the potential use of 3rd party food safety audit data as part of the Agency's inspection strategy.
ASTA Comments to FDA on Sesame Allergens
ASTA issued comments to the Food and Drug Administration (FDA) in December 2018 in response to the FDA's Request for Comment on Sesame as an Allergen in Foods. The comments support labeling sesame as a major allergen, provided that sufficient time is offered to implement new labeling and GMP requirements.
